Dr. Fooke Laboratorien

What Dr. Fooke Laboratorien does

Dr. Fooke-Achterrath Laboratorien GmbH (operating as Dr. Fooke Laboratorien) is a German in-vitro diagnostics manufacturer and accredited contract microbiology laboratory founded in 1988 and headquartered at Habichtweg 16, 41468 Neuss, Germany. The company employs 11-50 people and is led by founder Managing Director Dr. Margrit Fooke-Achterrath, with Kristina Fooke-Clemens as joint representative. It is registered under HRB 5712 at the commercial register of Neuss (tax ID DE120679339) and is privately held with no identified external equity or venture capital involvement.

The firm operates two revenue streams. Its core stream is the in-house development, production, and B2B sale of allergy and autoimmune in-vitro diagnostic test systems under proprietary brand platforms: ALLERG-O-LIQ (Sandwich ELISA for specific and total IgE using REAST technology on anti-human IgE-coated microtiter plates, with more than 500 allergen extracts and mixtures available), ALFA lateral flow assays (semi-quantitative specific IgE results in 15-20 minutes from serum, plasma, or whole blood), AI-LFAs autoimmune lateral flow assays, EAST allergen-coated disc immunoassays, ECP and Tryptase ELISAs, Microarray Food Screen for specific IgG4, ARTHUS artificial human sera quality controls, and Autoimmune ELISA Kits. REAST's key technical feature is the removal of interfering serum components to isolate allergen-specific IgE measurement. The second stream is accredited microbiological laboratory services — sampling, identification (including PCR), shelf-life studies, and certification — for food, drinking water, and cosmetics customers; this laboratory has held DIN EN ISO/IEC 17025 accreditation since 2005.

Diagnostics manufacturing is conducted under DIN EN ISO 13485 quality management. The company serves four verticals (clinical laboratories, food processors, water utilities, cosmetics manufacturers) using direct enterprise field sales with on-site product presentation and personal technical support. The firm serves more than 700 regional customers in microbiology and over 35 years of continuous in-vitro diagnostics experience. Geographic reach is limited to the DACH region, with no disclosed distribution partnerships, app, or API surface. Pricing, revenue, and contract terms are not publicly disclosed; no funding rounds, acquisitions, strategic partnerships, or restructuring actions have been identified. Sustainability milestones include 100% green electricity since 2017, a 90 kWp PV system since 2019, and climate-neutral production since 2022. The firm has been named a Top 100 Innovator in Germany for three consecutive years (2024-2026).

Name

Dr. Fooke Laboratorien

Legal name

Dr. Fooke-Achterrath Laboratorien GmbH

Website

https://fooke-labs.de

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

11–50 employees

Short description

Dr. Fooke Laboratorien is a German in-vitro diagnostics manufacturer and DIN EN ISO/IEC 17025-accredited microbiology laboratory based in Neuss, Germany, developing allergy (ALLERG-O-LIQ, ALFA, REAST/EAST) and autoimmune lateral flow and ELISA test kits sold B2B to clinical laboratories, plus accredited microbiological testing services for food, drinking water, and cosmetics customers across the DACH region.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Testing Laboratories and Services (541380)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Autoimmune, Allergy & Specialized Immunology Diagnostics (HLAHAAAK)

akta.pro secondary industry

Food Testing Laboratories (Microbiological, Chemical, Allergen) (AFALAAAA)

Keywords

• In-vitro diagnostics
• Allergy diagnostics
• Autoimmune diagnostics
• Microbiological testing
• Medical device manufacturing

Headquarters

HQ city

Neuss

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. In-vitro Diagnostic Products: Development, production and sale of allergy and autoimmune diagnostic test kits including ALLERG-O-LIQ, ALFA rapid tests, ELISA kits, and molecular allergy components. Products sold directly to laboratories and medical facilities.
2. Microbiological Testing Services: Laboratory services for microbiological analysis of food, drinking water, cosmetics, and hygiene controls. Services include sampling, testing, and certification for quality assurance purposes.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Dr. Fooke Laboratorien develops, manufactures, and sells in-vitro diagnostic test systems for allergy and autoimmune disease diagnostics, including the ALLERG-O-LIQ quantitative IgE system, ALFA rapid lateral flow assays, AI-LFAs for autoimmune testing, and ELISA-based kits. The company also provides accredited microbiology laboratory services for food, drinking water, and cosmetics testing under DIN EN ISO/IEC 17025.

Product overview

Dr. Fooke Laboratorien is an in-vitro diagnostics company offering a comprehensive portfolio of allergy and autoimmune diagnostic products. The core product line includes the ALLERG-O-LIQ system (Sandwich ELISA for specific and total IgE), ALFA rapid tests (lateral flow assays delivering results in 15-20 minutes), AI-LFAs for autoimmune testing, and REAST/EAST immunoassay systems. Supporting assays include ECP and Tryptase ELISAs, Specific IgG/IgG4 tests, and Microarray Food Screen for IgG4 detection. The company also provides ARTHUS quality control sera and Autoimmune ELISA Kits. Microbiology laboratory services cover food, drinking water, and cosmetics testing. All products are manufactured under ISO 13485 quality management with bioanalysis accredited to DIN EN ISO/IEC 17025.

Differentiator

Problem solved

Functional benefit

Brands

• ALLERG-O-LIQ: Quantitative determination system for specific IgE and total IgE based on REAST (Reversed Enzyme Allergo Sorbent Test) technology.
• ALFA
• AI-LFAs

Products and services

• ALLERG-O-LIQ Quantitative determination system for specific IgE and Total IgE using Sandwich ELISA in microtiter plates with more than 500 complete allergen extracts and allergen mixtures, available for 2-plate and 4-plate automation. Sold to medical laboratories and healthcare providers.
• ALFA (Allergy Lateral Flow Assay) Rapid lateral flow assay for semi-quantitative determination of specific IgE (sIgE) or total IgE in human serum, plasma, or whole blood, providing results within 15-20 minutes with 150 freely selectable allergen solutions. Used by clinical laboratories as a first-line screening test.
• AI-LFAs (Autoimmune Lateral Flow Assays) Rapid lateral flow assays enabling quick and reliable autoimmune disease testing for clinical diagnostics. Targets organ-specific, systemic, or intermediate autoimmune conditions.
• Molecular Allergy Diagnostics Diagnostic offering using recombinant or highly purified native allergens for Type I allergy diagnostics, enabling identification of primary sensitization, differentiation of sensitizations, and risk marker identification for precision treatment selection.
• REAST (Reversed Enzyme Allergo Sorbent Test) Quantitative determination of specific IgE in human serum or plasma using biotinylated allergens with anti-human IgE-coated microtiter plates; removes interfering serum components for accurate measurement with high sensitivity. Used in allergy diagnostics.
• EAST (Enzyme Allergo Sorbent-Test) Quantitative determination of allergen-specific IgE in human serum or plasma using allergen-coated discs for Type I allergy diagnostics.
• ECP ELISA ELISA for quantitative determination of Eosinophilic Cationic Protein (ECP) in human serum, used for monitoring allergic and inflammatory conditions.
• Tryptase ELISA ELISA for quantitative determination of total tryptase in human serum or plasma, used as an indicator of mast cell number and activity in allergic reactions.
• Specific IgG & IgG4 Enzyme Immunoassay Enzyme immunoassay for quantitative determination of specific IgG or specific IgG4 in human serum or plasma, supporting advanced allergy diagnostics.
• Microarray Food Screen Microarray for qualitative determination of specific IgG4 against food antigens in human serum or plasma, used for irritable bowel syndrome analysis and exclusion diets.
• ARTHUS Artificial Human Sera Artificial human sera providing well-defined quality controls for standardization of in-vitro allergy diagnostics, supporting development, production, and quality control of allergy test systems.
• Autoimmune ELISA Kits ELISA-based diagnostic kits for autoimmune diseases, covering organ-specific and systemic autoimmune conditions with high reliability. Sold to clinical laboratories.
• COVID-19/SARS-CoV-2 Antibody Test Test for determining the effectiveness of COVID-19 vaccination or detecting prior COVID-19 infection through antibody detection.
• Microbiology Laboratory Services Accredited microbiological analysis services for food, drinking water, and cosmetics including quality assurance, PCR-based microorganism identification, shelf life studies, sampling, hygiene controls, and certification. Serves more than 700 regional customers.

Quantifiable outcome

• Over 700 regional customers rely on microbiology services
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• EUROIMMUN (PerkinElmer): EUROIMMUN is a German-headquartered specialist in autoimmune and allergy diagnostics, with broad ELISA and immunoblot menus and a global distribution footprint. It is the closest direct competitor to Fooke's autoimmune ELISA and allergy immunoassay portfolio, sharing German Mittelstand origin and clinical laboratory customer base.
• Aesku.Diagnostics: Aesku.Group (parent of Aesku.Diagnostics and Aesku.Bio) is a German mid-sized company specializing in autoimmune diagnostics, ELISA kits, and autoantigen production. It directly competes with Fooke's autoimmune ELISA kits and AI-LFA rapid tests in clinical laboratories across DACH and internationally.
• GA Generic Assays: GA Generic Assays is a German developer and manufacturer of in-vitro allergy and autoimmune diagnostic kits, including ELISA and immunoblot systems. It is a closely comparable specialty IVD competitor with similar product architecture (allergen-coated plates, autoimmune ELISAs) and a comparable Mittelstand footprint.
• R-Biopharm: R-Biopharm is a German mid-sized diagnostics and food analysis company offering clinical diagnostics and food/water microbiology testing. It is directly comparable in scale, German Mittelstand profile, and the dual focus on IVD products plus food/water microbiological services, mirroring Fooke's business mix.

Broad incumbents

• Bio-Rad Laboratories: Bio-Rad is a US-headquartered life-science and clinical diagnostics company with a substantial autoimmune and infectious disease ELISA product line, plus quality controls. It overlaps with Fooke's autoimmune ELISA kits and ARTHUS QC sera offerings and serves a similar clinical laboratory customer base globally.
• Thermo Fisher Scientific (Phadia): Phadia (now part of Thermo Fisher) is the global market leader in allergy diagnostics, including the ImmunoCAP specific IgE platform. While far larger and broader, its specific-IgE and autoimmune immunoassay line directly competes with Fooke's ALLERG-O-LIQ and ALFA products in hospital and reference lab accounts.
• Siemens Healthineers: Siemens Healthineers operates a broad IVD and laboratory diagnostics portfolio including allergy and autoimmune assays integrated with its central-lab analyzers. It is a broad incumbent serving the same clinical laboratory buyers as Fooke, though with bundled, integrated immunoassay platforms rather than dedicated allergy specialization.

Regional players

• Romer Labs: Romer Labs is a food-safety diagnostics company offering testing solutions and laboratory services for mycotoxins, allergens, and microbiological contaminants. It overlaps with Fooke's food-industry microbiology and allergen testing services and shares a focus on regulated food-industry buyers, though with a different geographic and product emphasis.
• SGS (SGS Institut Fresenius): SGS operates a global network of accredited food, water, cosmetics, and environmental testing laboratories including SGS Institut Fresenius in Germany. It competes with Fooke's microbiology services segment for food-industry, drinking water, and cosmetics clients, and holds comparable DIN EN ISO/IEC 17025 accreditation.

Emerging players

• HYCOR Biomedical: HYCOR Biomedical is an allergy and autoimmune diagnostics company offering specific IgE and autoantibody testing platforms. It is an emerging player with overlapping specific-IgE and autoimmune assay offerings targeted at clinical laboratories, competing on similar menu and workflow lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dr. Fooke Laboratorien